{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:24:20Z","timestamp":1770960260748,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jpedsurg.2012.10.043","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T04:18:03Z","timestamp":1358223483000},"page":"47-55","source":"Crossref","is-referenced-by-count":9,"title":["Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model"],"prefix":"10.1016","volume":"48","author":[{"given":"Joseph E.","family":"Hartwich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Shannon","family":"Orr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine Y.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyu","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian M.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne L.","family":"Furman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Davidoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpedsurg.2012.10.043_bb0005","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.1998.16.3.953","article-title":"Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry","volume":"16","author":"Ladenstein","year":"1998","journal-title":"J Clin Oncology"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pbc.21784","article-title":"Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis retinoic acid: a report from the Children's Oncology Group","volume":"52","author":"Park","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0015","first-page":"49","article-title":"RANKL\/RANK\/OPG: new therapeutic targets in bone tumors and associated osteolysis","volume":"1704","author":"Wittrant","year":"2004","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0020","first-page":"1637","article-title":"Receptor activator of nuclear factor \u03baB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma","volume":"61","author":"Michigami","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2174\/156800909789760375","article-title":"Denosumab: the era of targeted therapies in bone metastatic diseases","volume":"9","author":"Santini","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0030","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.20308","article-title":"In Vitro blockade of receptor activator of nuclear factor-\u03baB ligand prevents osteoclastogenesis induced by neuroblastoma cells","volume":"111","author":"Granchi","year":"2004","journal-title":"Int J Cancer"},{"issue":"3 Suppl","key":"10.1016\/j.jpedsurg.2012.10.043_bb0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007 a recombinant osteoprotegerin construct in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpedsurg.2008.10.041","article-title":"Neural progenitor-cell mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis","volume":"44","author":"Sims","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/pbc.21296","article-title":"Initial testing (stage I) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program","volume":"50","author":"Houghton","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/bjp.2008.167","article-title":"Rapamycin affects early fracture healing in mice","volume":"154","author":"Holstein","year":"2008","journal-title":"Brit J Pharm"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2009.04.084","article-title":"Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells","volume":"384","author":"Mogi","year":"2009","journal-title":"Biochem Biophys Rsch Comm"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0060","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jpedsurg.2007.02.027","article-title":"In vivo bioluminescence imaging for early detection and monitoring of disease in a murine model of neuroblastoma","volume":"42","author":"Dickson","year":"2007","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2012.10.043_bb0065","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adenoassociated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.jpedsurg.2012.10.043_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.surg.2006.02.004","article-title":"Efficacy of zoledronate against neuroblastoma","volume":"140","author":"Dickson","year":"2006","journal-title":"Surgery"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346812008718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346812008718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T14:02:58Z","timestamp":1539957778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346812008718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0022346812008718"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2012.10.043","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}